Tapewire

Nasdaq · USD

SRTS

Sensus Healthcare, Inc.

Export transactions ↓
Tapewire entity
7142
SEC CIK
0001494891
Parsed reports
184

Last 12 months

Inside the activity.

21 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025110
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202680
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 13, 2022 Filed Sep 15, 2022 13:12 UTC
Sardano MichaelPRESIDENT AND GENERAL COUNSEL
SaleCommon Stock 5,000 $14.13 $70,627.50
Disclosure

SEC source: 0001415889-22-009635 · form4-09152022_060928.xml · nonDerivative · entry 2

Sardano Michael · CIK 0001720602 · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,519

F1 · price: This represents the average price per share. The shares sold at prices ranging from $14.07 to $14.156.

Read SEC document
September 13, 2022 Filed Sep 15, 2022 13:12 UTC
Sardano MichaelPRESIDENT AND GENERAL COUNSEL
Exercise / conversionCommon Stock 5,000 $5.55 $27,750.00
Disclosure

SEC source: 0001415889-22-009635 · form4-09152022_060928.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,519

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 07, 2022 Filed Sep 7, 2022 20:41 UTC
Sardano Joseph CDirector · Chief Executive Officer
SaleCommon Stock 15,794 $12.58 $198,642.72
Disclosure

SEC source: 0001300111-22-000001 · primary_doc.xml · nonDerivative · entry 3

Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,130,293

F3 · price: This represents the average price per share. The shares were sold at prices ranging from $12.54 to $12.70.

Read SEC document
September 06, 2022 Filed Sep 7, 2022 20:41 UTC
Sardano Joseph CDirector · Chief Executive Officer
SaleCommon Stock 15,794 $12.56 $198,446.87
Disclosure

SEC source: 0001300111-22-000001 · primary_doc.xml · nonDerivative · entry 2

Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,146,087

F2 · price: This represents the average price per share. The shares were sole at prices ranging from $12.50 to $12.61.

Read SEC document
September 02, 2022 Filed Sep 7, 2022 20:41 UTC
Sardano Joseph CDirector · Chief Executive Officer
SaleCommon Stock 10,000 $12.42 $124,168.00
Disclosure

SEC source: 0001300111-22-000001 · primary_doc.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,161,881

F1 · price: This represents the average price per share. The shares were sold at prices ranging from $12.40 to $12.47.

Read SEC document
August 11, 2022 Filed Aug 11, 2022 20:58 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 28,999 $14.21 $412,217.89
Disclosure

SEC source: 0001415889-22-008495 · form4-08112022_010832.xml · nonDerivative · entry 3

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,171,881

F3 · price: This represents the average price per share. The shares were sold from prices ranging from $13.76 to $14.37.

Read SEC document
August 10, 2022 Filed Aug 10, 2022 16:17 UTC SaleCommon Stock 39,978 $14.26 $570,254.19
Disclosure

SEC source: 0001415889-22-008461 · form4-08102022_010832.xml · nonDerivative · entry 2

O'Rear Samuel · CIK 0001670026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,570

F2 · price: This represents the average price per share. The shares were sold from prices ranging from $14 to $14.475.

Read SEC document
August 10, 2022 Filed Aug 11, 2022 20:58 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 93,320 $14.16 $1,321,196.56
Disclosure

SEC source: 0001415889-22-008495 · form4-08112022_010832.xml · nonDerivative · entry 2

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,200,880

F2 · price: This represents the average price per share. The shares were sold from prices ranging from $14 to $14.48.

Read SEC document
August 09, 2022 Filed Aug 10, 2022 16:17 UTC SaleCommon Stock 10,022 $13.96 $139,942.20
Disclosure

SEC source: 0001415889-22-008461 · form4-08102022_010832.xml · nonDerivative · entry 1

O'Rear Samuel · CIK 0001670026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,548

F1 · price: This represents the average price per share. The shares were sold from prices ranging from $13.9 to $14.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:58 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 36,093 $13.97 $504,064.01
Disclosure

SEC source: 0001415889-22-008495 · form4-08112022_010832.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,294,200

F1 · price: This represents the average price per share. The shares were sold from prices ranging from $13.92 to $14.132.

Read SEC document
July 21, 2022 Filed Jul 25, 2022 15:44 UTC
Rampolla JavierCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 3,935 $10.51 $41,356.85
Disclosure

SEC source: 0001415889-22-007940 · form4-07252022_120706.xml · nonDerivative · entry 1

Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,856

F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock.

Read SEC document
July 21, 2022 Filed Jul 25, 2022 19:45 UTC
Sardano MichaelPRESIDENT AND GENERAL COUNSEL
Tax withholdingCommon Stock 3,935 $10.51 $41,356.85
Disclosure

SEC source: 0001415889-22-007942 · form4-07252022_120744.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,519

F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock.

Read SEC document
July 21, 2022 Filed Apr 22, 2026 16:18 UTC Amendment
Rampolla JavierCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 3,935 $10.51 $41,356.85
Disclosure

SEC source: 0001800068-26-000003 · form4a-04222026_080428.xml · nonDerivative · entry 1

Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,114

F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock.

F2 · balance_after: On July 25, 2022, the reporting person filed a Form 4 (the "Original Report") which inadvertently reported that the reporting person owned 48,856 shares of the issuer's common stock as of July 21, 2022. In fact, the reporting person held 48,114 shares of the issuer's common stock as of July 21, 2022. As a result of the error in the Original Report, the number of shares of common stock beneficially owned by the reporting person as reported on each Form 4 filed by the reporting person between the date of the Original Report and the filing of this amendment to the Original Report was overstated by 742 shares.

Read SEC document
May 10, 2022 Filed May 12, 2022 10:27 UTC SaleCommon Stock 5,000 $7.55 $37,750.00
Disclosure

SEC source: 0001415889-22-004878 · form4-05122022_070518.xml · nonDerivative · entry 2

McCall William H · CIK 0001670233 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,723

Read SEC document
May 10, 2022 Filed May 12, 2022 10:27 UTC SaleCommon Stock 5,000 $7.53 $37,650.00
Disclosure

SEC source: 0001415889-22-004878 · form4-05122022_070518.xml · nonDerivative · entry 1

McCall William H · CIK 0001670233 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 330,723

Read SEC document
May 10, 2022 Filed Jul 17, 2024 09:17 UTC Amendment SaleCommon Stock 5,000 $7.55 $37,750.00
Disclosure

SEC source: 0001415889-24-019619 · form4a-07172024_010712.xml · nonDerivative · entry 2

McCall William H · CIK 0001670233 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

F1 · balance_after: On May 10, 2022, the reporting person filed a Form 4 that inadvertently reported that, following the reported transactions, the reporting person beneficially owned 325,723 shares directly. This Form 4 is being amended to reflect the correct amount of shares beneficially owned, directly and indirectly, by the reporting person following each reported transaction.

Read SEC document
May 10, 2022 Filed Jul 17, 2024 09:17 UTC Amendment SaleCommon Stock 5,000 $7.53 $37,650.00
Disclosure

SEC source: 0001415889-24-019619 · form4a-07172024_010712.xml · nonDerivative · entry 1

McCall William H · CIK 0001670233 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

F1 · balance_after: On May 10, 2022, the reporting person filed a Form 4 that inadvertently reported that, following the reported transactions, the reporting person beneficially owned 325,723 shares directly. This Form 4 is being amended to reflect the correct amount of shares beneficially owned, directly and indirectly, by the reporting person following each reported transaction.

Read SEC document
March 21, 2022 Filed Jul 17, 2024 09:20 UTC OtherCommon Stock 325,723 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-019621 · form4-07172024_010728.xml · nonDerivative · entry 1

McCall William H · CIK 0001670233 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Investors Capital Alliance, LLC

Disclosed balance after: 0

F1 · date: The reporting person indirectly held these shares through Investors Capital Alliance, LLC ("ICA"). All such shares are believed to have been misappropriated by a partner of ICA and subsequently sold in various transaction between March 21, 2022 and November 9, 2023. The reporting person was not aware of the sales at the time they were made and has received no benefit, and does not anticipate receiving any benefit, in connection with the sales.

F1 · shares: The reporting person indirectly held these shares through Investors Capital Alliance, LLC ("ICA"). All such shares are believed to have been misappropriated by a partner of ICA and subsequently sold in various transaction between March 21, 2022 and November 9, 2023. The reporting person was not aware of the sales at the time they were made and has received no benefit, and does not anticipate receiving any benefit, in connection with the sales.

Read SEC document
March 11, 2022 Filed Mar 11, 2022 21:52 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 44,782 $10.11 $452,643.02
Disclosure

SEC source: 0001415889-22-002898 · form4-03112022_010341.xml · nonDerivative · entry 3

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,330,293

F3 · price: This represents the average price per share. The shares were sold from prices ranging from $10.05 to $10.23.

Read SEC document
March 10, 2022 Filed Mar 11, 2022 21:52 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 38,300 $10.18 $389,932.30
Disclosure

SEC source: 0001415889-22-002898 · form4-03112022_010341.xml · nonDerivative · entry 2

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,375,075

F2 · price: This represents the average price per share. The shares were sold from prices ranging from $10.05 to $10.29.

Read SEC document
March 09, 2022 Filed Mar 10, 2022 16:06 UTC
Soro NicolasCHIEF OPERATING OFFICER
Exercise / conversionEmployee Stock Options (right to buy) · Derivative 10,000 $0.00 Strike: $5.55 $0.00
Disclosure

SEC source: 0001415889-22-002820 · form4-03102022_080316.xml · derivative · entry 3

Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2028-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options vested in four equal annual installments beginning on January 25, 2019.

Read SEC document
March 09, 2022 Filed Mar 10, 2022 16:06 UTC
Soro NicolasCHIEF OPERATING OFFICER
SaleCommon Stock 10,000 $10.20 $102,000.00
Disclosure

SEC source: 0001415889-22-002820 · form4-03102022_080316.xml · nonDerivative · entry 2

Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,546

F1 · price: This represents the average price per share. The shares were sold from prices ranging from $10.04 to $10.42.

Read SEC document
March 09, 2022 Filed Mar 10, 2022 16:06 UTC
Soro NicolasCHIEF OPERATING OFFICER
Exercise / conversionCommon Stock 10,000 $5.55 $55,500.00
Disclosure

SEC source: 0001415889-22-002820 · form4-03102022_080316.xml · nonDerivative · entry 1

Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,546

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 21:52 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 50,274 $10.19 $512,206.59
Disclosure

SEC source: 0001415889-22-002898 · form4-03112022_010341.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,413,375

F1 · price: This represents the average price per share. The shares were sold from prices ranging from $10.05 to $10.55.

Read SEC document
March 04, 2022 Filed Mar 8, 2022 13:34 UTC
Rampolla JavierCHIEF FINANCIAL OFFICER
SaleCommon Stock 9,000 $9.42 $84,780.00
Disclosure

SEC source: 0001415889-22-002727 · form4-03082022_100313.xml · nonDerivative · entry 2

Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,049

Read SEC document
March 04, 2022 Filed Mar 8, 2022 13:34 UTC
Rampolla JavierCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 9,000 $5.50 $49,500.00
Disclosure

SEC source: 0001415889-22-002727 · form4-03082022_100313.xml · nonDerivative · entry 1

Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 03, 2022 Filed Mar 10, 2022 16:05 UTC
Soro NicolasCHIEF OPERATING OFFICER
Tax withholdingCommon Stock 742 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-002818 · form4-03102022_080355.xml · nonDerivative · entry 1

Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,546

Read SEC document
February 01, 2022 Filed Mar 8, 2022 13:34 UTC
Rampolla JavierCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 742 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-002727 · form4-03082022_100313.xml · nonDerivative · entry 3

Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,049

F1 · balance_after: The amounts shown have been adjusted to correct errors in previous filings.

Read SEC document
December 17, 2021 Filed Dec 17, 2021 13:50 UTC
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
SaleCommon Stock 28,771 $7.06 $202,993.79
Disclosure

SEC source: 0001415889-21-006062 · form4-12172021_101255.xml · nonDerivative · entry 3

Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 830,585

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F4 · price: The sale prices range from $6.85 through $7.29.

Read SEC document
December 16, 2021 Filed Dec 17, 2021 13:50 UTC
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
SaleCommon Stock 5,321 $7.06 $37,592.33
Disclosure

SEC source: 0001415889-21-006062 · form4-12172021_101255.xml · nonDerivative · entry 2

Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 859,356

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F3 · price: The sale prices range from $6.8525 through $7.26.

Read SEC document
December 16, 2021 Filed Dec 17, 2021 18:48 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 10,926 $7.02 $76,676.48
Disclosure

SEC source: 0001415889-21-006059 · form4-12172021_101201.xml · nonDerivative · entry 2

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,463,649

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F3 · price: The sale prices range from $6.85 through $7.25.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 13:50 UTC
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
SaleCommon Stock 13,253 $6.99 $92,638.47
Disclosure

SEC source: 0001415889-21-006062 · form4-12172021_101255.xml · nonDerivative · entry 1

Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 864,677

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F2 · price: The sale prices range from $6.87 through $7.45.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 18:48 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 13,301 $6.99 $92,962.02
Disclosure

SEC source: 0001415889-21-006059 · form4-12172021_101201.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,474,575

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F2 · price: The sale prices range from $6.85 through $7.45.

Read SEC document
December 14, 2021 Filed Dec 15, 2021 15:43 UTC
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
SaleCommon Stock 14,889 $7.22 $107,558.14
Disclosure

SEC source: 0001415889-21-005957 · form4-12152021_121244.xml · nonDerivative · entry 1

Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 882,833

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F2 · price: The sale prices range from $6.85 through $7.46.

Read SEC document
December 14, 2021 Filed Dec 15, 2021 20:42 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 13,969 $7.22 $100,824.05
Disclosure

SEC source: 0001415889-21-005956 · form4-12152021_121241.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,492,479

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F2 · price: The sale prices range from $6.86 through $7.46.

Read SEC document
December 14, 2021 Filed Dec 16, 2021 16:58 UTC Amendment
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
SaleCommon Stock 14,889 $7.22 $107,558.14
Disclosure

SEC source: 0001415889-21-006037 · form4a-12162021_011207.xml · nonDerivative · entry 2

Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 877,930

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F3 · price: The sale prices range from $6.85 through $7.46.

Read SEC document
December 14, 2021 Filed Dec 16, 2021 16:58 UTC Amendment
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
SaleCommon Stock 14,889 $7.22 $107,558.14
Disclosure

SEC source: 0001415889-21-006036 · form4a-12162021_011207.xml · nonDerivative · entry 2

Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 877,930

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F3 · price: The sale prices range from $6.85 through $7.46.

Read SEC document
December 14, 2021 Filed Dec 16, 2021 21:56 UTC Amendment
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 13,969 $7.22 $100,824.05
Disclosure

SEC source: 0001415889-21-006035 · form4a-12162021_011245.xml · nonDerivative · entry 2

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,487,876

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F3 · price: The sale prices range from $6.86 through $7.46.

Read SEC document
December 13, 2021 Filed Dec 16, 2021 16:58 UTC Amendment
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
SaleCommon Stock 4,903 $6.99 $34,266.09
Disclosure

SEC source: 0001415889-21-006037 · form4a-12162021_011207.xml · nonDerivative · entry 1

Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 892,819

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F2 · price: The sale prices range from $6.80 through $7.27.

Read SEC document
December 13, 2021 Filed Dec 16, 2021 16:58 UTC Amendment
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
SaleCommon Stock 4,903 $6.99 $34,266.09
Disclosure

SEC source: 0001415889-21-006036 · form4a-12162021_011207.xml · nonDerivative · entry 1

Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 892,819

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F2 · price: The sale prices range from $6.80 through $7.27.

Read SEC document
December 13, 2021 Filed Dec 16, 2021 21:56 UTC Amendment
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 4,603 $6.98 $32,132.62
Disclosure

SEC source: 0001415889-21-006035 · form4a-12162021_011245.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,501,845

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F2 · price: The sale prices range from $6.78 through $7.40.

Read SEC document
December 10, 2021 Filed Dec 13, 2021 15:12 UTC
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
SaleCommon Stock 10,230 $7.78 $79,557.69
Disclosure

SEC source: 0001415889-21-005839 · form4-12132021_121213.xml · nonDerivative · entry 2

Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 897,722

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F3 · price: The sale prices range from $7.55 through $7.885.

Read SEC document
December 10, 2021 Filed Dec 13, 2021 20:10 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 10,271 $7.78 $79,895.03
Disclosure

SEC source: 0001415889-21-005838 · form4-12132021_121218.xml · nonDerivative · entry 2

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,506,448

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F3 · price: The sale prices range from $7.58 through $7.885.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 15:12 UTC
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
SaleCommon Stock 22,633 $7.81 $176,761.47
Disclosure

SEC source: 0001415889-21-005839 · form4-12132021_121213.xml · nonDerivative · entry 1

Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 907,952

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F2 · price: The sale prices range from $7.35 through $7.99.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 20:10 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 21,930 $7.79 $170,893.91
Disclosure

SEC source: 0001415889-21-005838 · form4-12132021_121218.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,516,719

F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F2 · price: The sale prices range from $7.35 through $7.98.

Read SEC document
July 21, 2021 Filed Jul 23, 2021 11:21 UTC
Rampolla JavierCHIEF FINANCIAL OFFICER
Grantcommon stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-21-003693 · form4-07232021_080719.xml · nonDerivative · entry 1

Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,878

F1 · shares: Represents 40,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant.

Read SEC document
July 21, 2021 Filed Jul 23, 2021 11:27 UTC Grantcommon stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-21-003695 · form4-07232021_080701.xml · nonDerivative · entry 1

McCall William H · CIK 0001670233 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,723

F1 · shares: Represents 10,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant.

Read SEC document
July 21, 2021 Filed Jul 23, 2021 11:37 UTC Grantcommon stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-21-003698 · form4-07232021_080732.xml · nonDerivative · entry 1

Heinrich John · CIK 0001669988 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,940

F1 · shares: Represents 10,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant.

Read SEC document
July 21, 2021 Filed Jul 23, 2021 11:24 UTC Grantcommon stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-21-003694 · form4-07232021_080703.xml · nonDerivative · entry 1

O'Rear Samuel · CIK 0001670026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,570

F1 · shares: Represents 10,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant.

Read SEC document
July 21, 2021 Filed Jul 23, 2021 15:40 UTC Grantcommon stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-21-003700 · form4-07232021_080733.xml · nonDerivative · entry 1

Petrelli Anthony Benedict · CIK 0001354750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,466

F1 · shares: Represents 10,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.